Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus

NCT01041625 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Lichen Planus

Interventions

DRUG: Apremilast (CC-10004)

Sponsor

Virginia Clinical Research, Inc.

Collaborators

[object Object]